The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 8.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (20 analysts) rates it buy, with a mean price target of $1532.
Fair Isaac
FICO · a US exchange · USD · Market cap $21.2B · 3,758 employees
Fair Isaac Corporation provides analytics software in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Fair Isaac holds its Distribution at $983.19. Consolidating, no directional conviction, held for 1 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $983.19 |
| Valuation | 28.47 trailing · 18.53 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.32 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 164.60% | Below 33% | Interest-bearing debt is 164.6% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 2.92% | Below 33% | Cash held in interest-bearing accounts and securities is 2.9% of assets, under the one-third limit. | Pass |
| Receivables | 35.51% | Below 49% | Money owed to the company is 35.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 48% discount to our $1,454.75 fair value, 25.70% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 48.0% margin of safety to the base estimate.
Third-party analyst targets: 19 covering, consensus Buy. The average target sits +56% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCredit score giant stumbles on debt screen
Every bank loan or credit card approval runs through FICO scores somewhere in the chain. The business posts 39 percent revenue growth and 34 percent profit margins, yet the ethical screen flags a debt ratio breach and we rate the name avoid.
The forward multiple sits at 23 times earnings with a 17 percent margin of safety to our fair value. That combination still fails the debt test, so we pass regardless of analyst targets clustered near 1522.
High margins can mask leverage that later bites when rates stay elevated. The unknown moat adds another layer of uncertainty we prefer to skip.
Analysis, not advice.
| Forward P/E | 18.5xcheap for a company growing this fast |
| Trailing P/E | 28.5xa premium valuation |
| EPS, trailing | 34.53 |
| EPS, forward | 53.06 |
| Revenue growth | +25.7%strong top-line growth |
| Profit margin | 34.1%highly profitable on every dollar of sales |
| FCF yield | 3.65% |
| Current ratio | 1.18adequate liquidity, worth monitoring |
| Beta | 1.32moves a little more than the market |
| Short interest, float | 0.10% |
| 52-week range | 870.01 - 1,998.01 |
| Market cap | $21.2B |
| Employees | 3,758 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFICO trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (20 analysts) rates it buy, with a mean price target of $1532.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (20 analysts) rates it buy, with a mean price target of $1532.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- How Fair Isaac (FICO) Is Deepening Its Mortgage Lending Moat Through Broader FICO Score 10T Adoption Insider Monkey · 15 Jul 2026
- Can CashAI Continue Powering Dave's Credit Growth Momentum Ahead? Zacks · 13 Jul 2026
- Equifax Expands in Mexico With $750 Million Círculo de Crédito Deal MarketBeat · 12 Jul 2026
- What to Expect From Fair Isaac’s Q3 2026 Earnings Report Barchart · 7 Jul 2026
- Beat the Market the Zacks Way: PDF Solutions, LifeStance Health, Paychex in Focus Zacks · 6 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | WEBER STEVEN P. | Chief Financial Officer | 706 | · | |
| 2026-03-04 | ARREDONDO FABIOLA R | Director | 154 | · | |
| 2026-03-04 | MANOLIS EVA | Director | 154 | · | |
| 2026-03-04 | REY DAVID A | Director | 94 | · | |
| 2026-03-04 | STANSBURY HENRY TAYLOE | Director | 77 | · | |
| 2026-03-04 | KELLY BRADEN R | Director | 171 | · | |
| 2026-03-04 | MCMORRIS MARC F | Director | 77 | · | |
| 2026-02-25 | MANOLIS EVA | Director | 520 | $128,866 | |
| 2026-02-25 | MANOLIS EVA | Director | 520 | $638,368 | |
| 2026-02-24 | REY DAVID A | Director | 3,192 | $791,041 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1,092.00 | +12.0% | · | $1,120 | +12.0% |
| 2 months | $922.37 | +32.6% | · | $1,326 | +32.6% |
| 3 months | $1,093.62 | +11.9% | · | $1,119 | +11.9% |
| 6 months | $1,825.83 | -33.0% | · | $670 | -33.0% |
| 1 year | $1,785.00 | -31.5% | · | $685 | -31.5% |
| 2 years | $1,310.15 | -6.6% | · | $934 | -6.6% |
| 3 years | $774.71 | +57.9% | · | $1,579 | +57.9% |
| 5 years | $504.78 | +142.4% | · | $2,424 | +142.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FICO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.